AUS
NZ
UK
CA
USA
IND
Healthcare
Why Paradigm’s Massive New Share Issue Is Drawing Attention
June 02, 2026 11:24 AM AEST| By SamParadigm Biopharmaceuticals has applied to quote more than forty-three million new shares on the ASX. The move expands tradable securities, enhances liquidity
Why Are ASX 300Healthcare Stocks Back on Market Radar?
June 01, 2026 02:09 PM AEST| By SamASX healthcare stocks remain in focus as biotech updates, regulatory milestones, medical devices, diagnostics, hospitals, and healthcare software shape sector activity.
ASX Healthcare Stocks Across ASX 100 Medical Sector
June 01, 2026 02:08 PM AEST| By SamExplore ASX healthcare stocks across biotechnology, medical devices, diagnostics, hospitals, imaging software, and respiratory care, including CSL, ResMed, Cochlear, Sonic Healthcare, Ramsay, Pro Medicus, and Fisher & Paykel.
ASX Healthcare Stocks Track Global Medical Demand
June 01, 2026 02:08 PM AEST| By SamASX healthcare names remain in focus as CSL, ResMed, Cochlear, Sonic Healthcare, Ramsay, Pro Medicus, and Fisher & Paykel shape sector activity.
Why Pro Medicus’ Latest Healthcare Deal Is Drawing Market Attention
June 01, 2026 10:00 AM AEST| By SamPro Medicus secured another US healthcare contract, highlighting growing adoption of its full Visage platform and cardiology capabilities.
Why Austco Healthcare’s US Expansion Could Be the Bigger Story
June 01, 2026 09:46 AM AEST| By SamAustco Healthcare delivered strong earnings growth while a large US Pulse Mobile deployment highlights growing software and recurring revenue opportunities.
Is Aroa Biosurgery Entering a New Era of Growth?
May 29, 2026 04:35 PM AEST| By SamAroa Biosurgery’s latest financial performance highlights profitability, healthcare market expansion, and evolving valuation discussions as investors assess the company’s long-term growth outlook.
Healthcare Stocks Enter a Catalyst-Rich Phase as Sector Eyes Fresh Momentum
May 29, 2026 04:29 PM AEST| By SamAustralian healthcare stocks are entering a catalyst-heavy phase with regulatory progress, clinical developments, commercial expansion, and innovation-led growth initiatives supporting sector-wide attention.
Why ASX Healthcare Names Keep Drawing Attention
May 29, 2026 02:21 PM AEST| By SamHealthcare companies remain active across radiopharmaceuticals, wound-care devices and diagnostic programs as commercial traction shapes sector discussion.
What Makes These ASX Healthcare Service Names Stand Out?
May 29, 2026 02:15 PM AEST| By SamSonic Healthcare, Healius and Integral Diagnostics operate across pathology, diagnostic services and imaging networks within Australia’s healthcare sector.
ASX 200 Healthcare Leaders Anchoring Market Strength
May 29, 2026 02:10 PM AEST| By SamASX healthcare stocks CSL, COH, and RMD showcase global medical innovation, device leadership, and therapy development across diverse healthcare segments.
Why Alcidion’s Latest Share Move Is Drawing Attention
May 29, 2026 11:00 AM AEST| By SamAlcidion continues drawing attention as digital healthcare expansion and new ASX share quotation activity remain in focus.
Why This ASX Healthcare Share Is Suddenly Back in the Spotlight
May 29, 2026 09:52 AM AEST| By SamImugene remains firmly on healthcare watchlists as oncology trial milestones and treatment development continue progressing.
Seaweed Trade Momentum Builds for BPH Global
May 28, 2026 08:12 PM AEST| By SamBPH Global strengthens its seaweed trading operations in Indonesia as favourable seasonal conditions support supply growth, stable demand and expanding opportunities across marine-based industries.
Australian Medical Shares Maintain Market Visibility
May 28, 2026 08:05 PM AEST| By SamHealthcare Stocks across Australian markets continue drawing attention as biotech companies, healthcare device manufacturers, and medical service providers expand operational activity.
Are ASX 200 Healthcare Stocks Back in Focus?
May 28, 2026 08:02 PM AEST| By SamASX Healthcare Stocks remain linked with biotechnology, medical devices, diagnostics, hospital services, and XHJ-led sector activity across Australia’s market.
Why Are Healthcare Stocks (ASX:COH, ASX:RMD) Holding ASX 200 Strong?
May 28, 2026 07:55 PM AEST| By SamHealthcare Stocks on the ASX highlight defensive sector characteristics, with stable demand, essential services, and key companies shaping market activity across global healthcare industries.
Nyrada Gains Market Attention Amid Growth Momentum
May 28, 2026 04:18 PM AEST| By SamNyrada is drawing investor attention through revenue expansion, innovation initiatives, and business growth momentum despite ongoing focus on cash management and future funding strategy.
Imugene Advances Cancer Therapy Research With New Clinical Milestone
May 28, 2026 03:14 PM AEST| By SamImugene advances its azer-cel clinical study with expanded patient enrolment and combination therapy research focused on blood cancer treatment innovation and broader global clinical development.
Recce Pharmaceuticals Gains Momentum Amid Strong Insider Confidence
May 28, 2026 03:11 PM AEST| By SamRecce Pharmaceuticals gains investor attention following strong insider participation and improving market sentiment, reinforcing confidence around the biotechnology company’s long-term growth journey.
Advertise your brand on Kalkine Media